Isolation of intact aortic valve scaffolds for heart-valve bioprostheses: Extracellular matrix structure, prevention from calcification, and cell repopulation features

Journal of Biomedical Materials Research - Part A

Volumn 67, Issue 4, 2003, Pages 1338-1350

  Spina, M ^a   Ortolani, F ^b   El Messlemani, A ^a   Gandaglia, A ^a   Bujan, J ^c   Garcia Honduvilla, N ^c   Vesely, I ^d   Gerosa, G ^a   Casarotto, D ^a   Petrelli, L ^b   Marchini, M ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Aortic valves; Calcification prevention; Cell repopulation; Extracellular matrix scaffold; Heart valve bioprostheses

Indexed keywords

CALCIFICATION (BIOCHEMISTRY); CELL MEMBRANES; DNA; ENZYMES; SCANNING ELECTRON MICROSCOPY; TISSUE;

AORTIC VALVE SCAFFOLDS;

HEART VALVE PROSTHESES;

CETYLPYRIDINIUM SALT; CHOLIC ACID; COLLAGEN FIBRIL; DNA; HEXOSAMINE; NUCLEASE; NUCLEIC ACID; PROTEOGLYCAN; TRITON X 100; URONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA VALVE; ARTICLE; BASEMENT MEMBRANE; BIOCOMPATIBILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM; EXTRACELLULAR MATRIX; FIBROBLAST; HEART VALVE BIOPROSTHESIS; MALE; MECHANICS; MONOLAYER CULTURE; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPY; SOFT TISSUE CALCIFICATION; SWINE; TISSUE ENGINEERING; ULTRASTRUCTURE;

EID: 0348014763     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.20025     Document Type: Article

References (57)

1. Schoen FJ. Pathology of bioprostheses and other tissue heart valve replacements. In: Silver MD, editor. Cardiovascular pathology, New York: Churchill Livingstone; 1991. p 1547-1605.
2. Mitchell RN, Jonas RA, Schoen FJ. Structure-function correlations in cryopreserved allograft cardiac valves. Ann Thorac Surg 1995;60:S108-S113.
3. Schoen FJ, Levy RJ. Tissue heart Valves: Current challenges and future research perspectives. J Biomed Mater Res 1999;47: 439-465.
4. Levy RJ, Schoen FJ, Sherman FS, Nichols J, Hawley MA, Lund SA. Calcification of subcutaneously implanted type I collagen sponges. Effects of formaldehyde and glutaraldehyde pretreatments. Am J Pathol 1986;122:71-82.
5. Golomb G, Schoen FJ, Smith MS, Linden J, Dixon M, Levy RJ. The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol 1987;127:122-130.
6. Valente ML, Bortolotti U, Thiene G. Ultrastructural substrates of dystrophic calcification in porcine bioprosthetic valve failure. Am J Pathol 1985;119:12-21.
7. Girardot M-N, Torrianni M, Dillehay D, Girardot J-M. Role of glutaraldehyde in calcification of porcine heart valves: Comparing cusp and wall. J Biomed Mater Res 1995;29:793-801.
8. Bernacca JM, Fisher AC, Wilkinson R, Mackay TG, Wheatley DJ. Calcification and stress distribution in bovine pericardial heart valves. J Biomed Mater Res 1992;26:959-966.
9. Deck JD, Thubrikar MJ, Schneider PJ, Nolan SP. Structure, stress, and tissue repair in aortic valve leaflets. Cardiovasc Res 1988;22:7-16.
10. Talman EA, Boughner DR. Glutaraldehyde fixation alters the internal shear properties of porcine aortic heart valve tissue. Ann Thorac Surg 1995;60:S369-S373.
11. Vyavahare N, Ogle M, Schoen FJ, Zand R, Gloeckner DC, Sacks M, Levy RJ. Mechanisms of bioprosthetic heart valve failure: Fatigue causes collagen denaturation and glycosaminoglycan loss. J Biomed Mater Res 1999;46:44-50.
12. Gloeckner DC, Billiar KL, Sacks MS. Effects of mechanical fatigue on the bending properties of the porcine bioprosthetic heart valve. Am Soc Artic Intern Org J 1999;45:59-63.
13. Thubrikar MJ, Deck JD, Aouad J, Nolan SP. Role of mechanical stress in calcification of aortic bioprosthetic valves. J Thorac Cardiovasc Surg 1983;86:115-125.
14. Schmidt CE, Baier JM. Acellular vascular tissues: Natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000;21:2215-2231.
15. Vesely I. The hybrid autograft/xenograft aortic valve. J Heart Valve Dis 1997;6:292-295.
16. Courtman DW, Pereira CA, Omar S, Shari EL, Lee JM, Wilson GJ. Biomechanical and ultrastructural comparison of cryopreservation and a novel cellular extraction of porcine aortic valve leaflets. J Biomed Mater Res 1995;29:1507-1516.
17. Parnigotto PP, Rocco F, Grigioni M, Dettin M, Zussa C, Di Bello C, Polesel E, Spinazzi R, Daniele C, Abbate M, Valfrè C, Conconi MT. Tissue engineering of aortic heart valve on acellular matrix conduits: In vitro results. Proc EMBEC 1999; part II 1512-1513.
18. O'Brien MF, Goldstein S, Walsh S, Black KS, Elkins R, Clarke D. The SynerGraft valve; A new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Sem Thorac Cardiovasc Surg 1999;11:194-200.
19. Bader A, Steinhoff G, Strobl K, Schilling T, Brandes G, Mertsching H, Tsikas D, Froelich J, Haverich A. Engineering of human vascular aortic tissue based on a xenogenic starter matrix. Transplantation 2000;70:7-14.
20. Simionescu A, Simionescu D, Deac R. Biochemical pathways of tissue degeneration in bioprosthetic cardiac valves. The role of matrix metalloproteinases. Am Soc Artic Intern Org J 1996;42: M561-M567.
21. Vyavahare N, Jones PL, Tallapragada S, Levy RJ. Inhibition of matrix metalloproteinase activity attenuate tenascin-C production and calcification of implanted purified elastin in rats. Am J Pathol 2000;157:885-893.
22. Loose R, Schultze-Rhonhof U, Sievers H-H, Bernhard A. Preparing heart valve allografts for endothelial cell seeding. Transplant Proc 1993;25:3244-3246.
23. Vyavahare N, Hirsch D, Lerner E, Baskin JZ, Schoen FJ, Bianco R, Kruth HS, Zand R, Levy RJ. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation 1997;95:479-488.
24. Samouillan V, Dandurand-Lods J, Lamure A, Maurel E, Lacabanne C, Gerosa G, Venturini A, Casarotto D, Gherardini L, Spina M. Thermal analysis characterization of aortic tissues for cardiac valve bioprostheses. J Biomed Mater Res 1999;46:531-538.
25. Shon YH, Wolfinbarger L. Proteoglycan content in fresh and cryopreserved porcine aortic tissue. Cryobiology 1994;31:121-132.
26. Nestle M, Roberts WK. An extracellular nuclease from Serratia marcescens. II. Specificity of the enzyme. J Biol Chem 1969;244: 5219-5255.
27. Nestle M, Roberts WK. An extracellular nuclease from Serratia marcescens. I. Purification and some properties of the enzyme. J Biol Chem 1969;244:5213-5218.
28. Spina M, Friso A, Ewins AR, Parker KH, Winlove CP. Physicochemical properties of arterial elastin and its associated glycoproteins. Biopolymers 1999;49:255-265.
29. Filisetti-Cozzi TMCC, Carpita NC. Measurement of uronic acids without interference from neutral sugars. Anal Biochem 1991;197:157-162.
30. Cessi C, Piliego F. The determination of amino sugars in the presence of amino acids and glucose. Biochem J 1960;77:508-510.
31. Shibko S, Koivistoinen P, Tratnyek CA, Newhall AR, Friedman L. A method for sequential quantitative separation and determination of protein, RNA, DNA, lipid and glycogen from a single rat liver homogenate or from a subcellular fraction. Anal Biochem 1967;19:514-528.
32. Richards GM. Modifications of the diphenylamine reaction giving increased sensitivity and simplicity in the estimation of DNA. Anal Biochem 1974;57:369-376.
33. Spina M, Garbin G. Age-related chemical changes in human elastins from non-atherosclerotic areas of thoracic-aorta. Atherosclerosis 1976;24:267-279.
34. Schoen FJ, Tsao JW, Levy RJ. Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanism of bioprosthetic tissue mineralization. Am J Pathol 1986;123:134-145.
35. von Kossa J. Über die im Organismus künstlich erzeugbaren Verkalkungen. Beitr path Anat 1901;29:163-202.
36. Vesely I, Casaratto D, Gerosa G. Mechanics of cryopreserved aortic and pulmonary allografts. J Heart Valve Dis 2000;9:27-37.
37. Carew EO, Vesely I. Role of preconditioning and recovery time in repeated testing of aortic valve tissues: Validation through QLV theory. Ann Biomed Eng 2000;28:1093-1100.
38. Bujan J, Bellon JM, Navlet J, Honduvilla N, Hernando A, Turegano F. Seeding of expanded polytetrafluoroethylene (ePTFE) vascular grafts. A morphological study of porcine endothelial and fibroblast cells. Histol Histopathol 1992;7:635-642
39. Stock UA, Nagashima M, Khalil PN, Nollert GD, Herden T, Sperling JS, Moran A, Lien J, Martin DP, Schoen FJ, Vacanti JP, Mayer JE. Tissue-engineered valved conduits in the pulmonary circulation. J Thorac Cardiovasc Surg 2000;119:732-740.
40. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, Moran A, Guleserian KJ, Sperling J, Kaushal S, Vacanti JP, Schoen FJ, Mayer JE. Functional living trileaflet heart valves grown in vitro. Circulation 2000;102(suppl III):44-49.
41. Zilla P, von Oppell U, Deutsch M. The endothelium: A key to the future. J Cardiovase Surg 1993;8:32-60.
42. Helenius A, McCaslin DR, Fries E, Tanford C. Properties of detergents. Meth Enzymol 1979;56:734-749.
43. Halliwell B, Cuteridge JMC. Free radicals in biology and medicine, 3rd ed. Oxford, Oxford University Press, 1999.
44. Jones M, Eidbo EE, Stephen LH, Ferrans VJ, Clark RE. Anti-calcification treatments of bioprosthetic heart valves: In vivo studies in sheep. J Cardiovase Surg 1989;4:69-73.
45. nd International Symposium: Tissue engineering for heart valve substitutes, London (UK), June 2001.
46. Wu LNY, Yoshimori T, Genge BR, Sauer GR, Kirsch T, Ishikawa Y, Wuthier RE. Characterization of the nucleation core complex responsible for mineral induction by growth plate cartilage matrix vesicles. J Biol Chem 1993;33:25084-25094.
47. Hooper NM, Turner AJ. Ectoenzymes of the kidney microvillar membrane. Biochem J 1988;250:865-869.
48. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997;387:569-572.
49. Hanada K, Nihijima M, Akamatsu Y, Pagano RE. Both sphingolipids and cholesterol participate in the detergent insolubility of alkaline phosphatase, a glycosylphosphatidylinositol-anchored protein, in mammalian membranes. J Biol Chem 1995;270:6254-6260.
50. 3 preincubations. J Biomed Mater Res 1991;25:905-935.
51. Courtman DW, Pereira CA, Kashef V, McKomb D, Lee JM, Wilson GJ. Development of a pericardial acellular matrix biomaterial: Biochemical and mechanical effects of cell extraction. J Biomed Mater Res 1994;28:655-666.
52. Blumenthal NC. Mechanisms of inhibition of calcification. Clin Orthop Rel Res 1989;247:279-289.
53. Jorge-Herrero E, Fernández P, de la Torre N, Escudero C, García-Páez JM, Buján J, Castillo-Olivares JL. Inhibition of the calcification of porcine valve tissue by selective lipid removal. Biomaterials 1994;15:815-820.
54. Ortolani F, Petrelli L, Tubaro F, Spina M, Marchini M. Novel ultrastructural features as revealed by phtalocyanin reactions indicate cell priming for calcification in subdermally implanted aortic valves. Connect Tiss Res 2002;43:44-55.
55. Ortolani F, Tubaro F, Petrelli L, Gandaglia A, Spina M, Marchini M. Copper retention, calcium release and ultrastructural evidence indicate specific Cuprolinic blue uptake and peculiar modifications in mineralising aortic valves. Histochem J 2002;34:41-50.
56. Cebotari S, Mertsching H, Kallenbach K, Kostin S, Repin O, Batrinac A, Kleczka C, Ciubotaru A, Haverich A. Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 2002;106(suppl I):63-68.
57. Bertipaglia B, Ortolani F, Petrelli L, Gerosa G, Spina M, Pauletto P, Casarotto D, Marchini M, Sartore S. Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO Project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur). Ann Thorac Surg 2003;75:1276-1282.